ATE7598T1 - Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide. - Google Patents

Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.

Info

Publication number
ATE7598T1
ATE7598T1 AT79301858T AT79301858T ATE7598T1 AT E7598 T1 ATE7598 T1 AT E7598T1 AT 79301858 T AT79301858 T AT 79301858T AT 79301858 T AT79301858 T AT 79301858T AT E7598 T1 ATE7598 T1 AT E7598T1
Authority
AT
Austria
Prior art keywords
halogenated lower
compounds
alkoxycarbonylaminobenzimidazoles
parasiticides
halogen
Prior art date
Application number
AT79301858T
Other languages
English (en)
Inventor
Helmut Mrozik
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE7598T1 publication Critical patent/ATE7598T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2635—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving a phosphorus compound, e.g. Wittig synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Paper (AREA)
AT79301858T 1978-09-13 1979-09-10 Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide. ATE7598T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/941,997 US4174400A (en) 1978-09-13 1978-09-13 Anthelmintic benzimidazoles
EP79301858A EP0009361B1 (de) 1978-09-13 1979-09-10 Einen Halogen enthaltenden Substituenten umfassende 2-Alkoxycarbonylaminobenzimidazole, ihre Herstellung und ihre Verwendung als Parasitizide

Publications (1)

Publication Number Publication Date
ATE7598T1 true ATE7598T1 (de) 1984-06-15

Family

ID=25477431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79301858T ATE7598T1 (de) 1978-09-13 1979-09-10 Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.

Country Status (8)

Country Link
US (1) US4174400A (de)
EP (1) EP0009361B1 (de)
JP (1) JPS5540681A (de)
AT (1) ATE7598T1 (de)
AU (1) AU534087B2 (de)
DE (1) DE2967005D1 (de)
DK (1) DK380279A (de)
ZA (1) ZA794850B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845537A1 (de) * 1978-10-19 1980-04-30 Bayer Ag Benzimidazolylcarbamidsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS58174607A (ja) * 1982-04-02 1983-10-13 トスカ紳士服株式会社 縫成品の製造法
IL78703A (en) * 1985-05-10 1993-02-21 Benzon Alfred Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials
US5922913A (en) * 1998-11-06 1999-07-13 Srm Chemical, Ltd., Co. Process for nitrating aromatic amines
SI1341769T1 (sl) 2000-12-15 2008-02-29 Vertex Pharma Inhibitorji bakterijske giraze in njihove uporabe
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US7618974B2 (en) * 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8193352B2 (en) * 2003-01-31 2012-06-05 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7582641B2 (en) * 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8404852B2 (en) 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US20060004090A1 (en) * 2004-07-01 2006-01-05 Roberts William J Forskolin compositions and methods for administration
EP2643304A2 (de) * 2010-11-24 2013-10-02 Sequent Scientific Ltd. Verfahren zur herstellung von albendazol
ES2705923T3 (es) 2011-01-14 2019-03-27 Spero Trinem Inc Formas sólidas de inhibidor de girasa (R)-1-etil-3-[6-fluoro-5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1H-bencimidazol-2-il]urea
EP2663556B1 (de) 2011-01-14 2014-10-15 Vertex Pharmaceuticals Incorporated Verfahren zur herstellung von gyrase- und topoisomerase-iv-hemmern
EP2663558A1 (de) 2011-01-14 2013-11-20 Vertex Pharmaceuticals Incorporated Feste formen von gyrasehemmer-(r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl-}pyrimidin-5-yl-]7-(tetrahydrofuran-2-yl-)-1h-benzimidazol-2-yl-]harnstoff
SG191946A1 (en) 2011-01-14 2013-08-30 Vertex Pharma Pyrimidine gyrase and topoisomerase iv inhibitors
CN103702994B (zh) 2011-06-20 2016-03-23 沃泰克斯药物股份有限公司 旋转酶和拓扑异构酶抑制剂的磷酸酯
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
WO2014015105A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE666795A (de) * 1964-08-04 1966-01-13
US3929824A (en) * 1972-12-29 1975-12-30 Syntex Inc 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3929821A (en) * 1972-12-29 1975-12-30 Syntex Inc 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives
DE2332398A1 (de) * 1973-06-26 1975-01-23 Hoechst Ag 2-carbalkoxy-amino-benzimidazol-5(6)phenylaether, ihre herstellung und verwendung in mitteln gegen helminthen
US3929823A (en) * 1973-11-21 1975-12-30 Syntex Inc 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3993768A (en) * 1974-11-25 1976-11-23 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
IT1076022B (it) * 1977-04-20 1985-04-22 Montedison Spa Benzimidazolcarbammati antielmintici

Also Published As

Publication number Publication date
EP0009361A1 (de) 1980-04-02
US4174400A (en) 1979-11-13
JPS5540681A (en) 1980-03-22
DK380279A (da) 1980-03-14
ZA794850B (en) 1981-04-29
EP0009361B1 (de) 1984-05-23
DE2967005D1 (en) 1984-06-28
AU534087B2 (en) 1984-01-05
AU5060779A (en) 1980-03-20

Similar Documents

Publication Publication Date Title
ATE7598T1 (de) Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.
BR9006840A (pt) Compostos heterociclicos
KR890701566A (ko) 헤테로사이클릭 화합물
YU157191A (sh) Antagonisti receptora fibrinogena
DK0718293T3 (da) Cyclodepsipeptidforbindelse
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
DE69011318D1 (de) Diazinderivate als Angiotensin II Rezeptor Antagonisten.
BG95344A (bg) Фунгицидни оксазолидинони
DK307289D0 (da) Pyrimidinderivater
DE69613710D1 (de) Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
ATE26270T1 (de) Substituierte (amino-2-ethyl)-6-benzoxazolinone, ihre herstellung und pharmazeutische zusammenstellung die sie enthaelt.
FI881404A0 (fi) Framstaellning av 4-/4-/4-/4-//2-(2,4 -difluorfenyl)-2-(1h-azolylmetyl)-1,3-dioxolan-4-yl/metoxi/fenyl/ -1-piperazinyl/fenyl/triazoloner.
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
DE59008356D1 (de) Heterocyclische Verbindungen.
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
DE69112070D1 (de) Anthelmintische und coccidizide 3-carbamoyl-4-hydroxycumarine, ihre verwendung und zusammensetzungen.
JPS5716841A (en) Novel compound,manufacture,bactericidal composition and use
DE69912193D1 (de) Substituierte 2-Hydroxybenzophenone, ihre Herstellung, ihre Verwendung als fungizide und ihre fungizide Zusammensetzungen
DE69002340D1 (de) Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl) mit serotoninergischer wirkung.
ATE9899T1 (de) Pyridinderivate, ihre herstellung und verwendung.
FR2364910A1 (fr) Nouvelles thiazolidines, leur preparation et leur application comme agent de lutte contre les parasites
ES2053808T3 (es) Nuevos compuestos azolicos.
ATE92479T1 (de) Neue 1,3-oxazine.